Severe secondary hyperkalemia and arrhythmia from drug interactions between calcium‐channel blocker and voriconazole: a case presentation

BACKGROUND: Patients with kidney disease may have concurrent hypertension and infection. Dihydropyridine calcium-channel blockers (CCB) are the most popular class of antihypertensive drugs used in clinical settings and can be metabolized by cytochrome P450 isoenzyme 3A4 (CYP3A4). Voriconazole is a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinju, Zhang, Chunyan, Zhu, Li, Wu, Bei, Han, Yun, Heung, Michael, Zuo, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108408/
https://www.ncbi.nlm.nih.gov/pubmed/33971831
http://dx.doi.org/10.1186/s12882-021-02370-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108408/
https://www.ncbi.nlm.nih.gov/pubmed/33971831
http://dx.doi.org/10.1186/s12882-021-02370-6

Ejemplares similares